Tricyclic 5-HT.sub.3 receptor antagonists

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

514211, 514872, 540520, 546 99, 546100, C07D47108, A61K 3155, A61K 31455

Patent

active

052023338

ABSTRACT:
The present invention is directed to 5-HT.sub.3 receptor antagonist compounds of formula I: ##STR1## in which the dashed line denotes an optional double bond;

REFERENCES:
patent: 3341528 (1967-09-01), Shavel, Jr.
patent: 3896132 (1975-07-01), Bernauer
patent: 4309543 (1982-01-01), Keeley
patent: 4571396 (1986-01-01), Hutt
patent: 4959367 (1990-09-01), King et al.
Reynolds, J. C. 1989, Prokinetic Agents: A Key in the Future of Gastroenterology, Gastroenterology Clinics of North America, 18:437-457.
1989, Drugs Acting on 5-Hydroxytryptamine Receptors, The Lancet, pp. 717-719.
Scholtysik, G. 1988, 5-Hydroxytryptamine Antagonist ICS 205-930 Blocks Cardiac Potassium, Sodium and Calcium Channels, J. of Pharmacol. Exp. Ther. 245, 3:773-778.
King et al. 1990, Benzotriazinones as "Virtual Ring" Mimics of o-Methoxybenzamides: Novel and Potent 5-HT.sub.3 Receptor Antagonists, J. Med. Chem. 33:2942-2944.
Peatfield, R. 1988, Drugs and the treatment of Migraine, Trends Pharmacol. Sci. 9:141-145.
Komatsu et al. 1978, Chem. Abs. 89:100352x.
Hibert et al. 1988, Preparation and testing of 4-(2-pyrimidinyl)-1-piperazinepyrimidinediones and -oxazinones as minor tranquilizers, Chem. Abs. 108:221716p.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Tricyclic 5-HT.sub.3 receptor antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Tricyclic 5-HT.sub.3 receptor antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Tricyclic 5-HT.sub.3 receptor antagonists will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-1155622

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.